종근당
Not investment advice · For research purposes only; not a solicitation or an offer of any financial product. Past statistics do not indicate future outcomes. Facts from filings and public sources; not investment advice. No valuation estimate, direction or trading levels are provided.
① Fact table
Values as filed · consolidated / separate basis per year · no interpretation
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | Unit |
|---|---|---|---|---|---|---|
| Revenue | KRW 1.3tn | KRW 1.5tn | KRW 1.7tn | KRW 1.6tn | KRW 1.7tn | KRW |
| Operating income | KRW 94.8bn | KRW 109.9bn | KRW 246.6bn | KRW 99.5bn | KRW 80.6bn | KRW |
| Net income | KRW 42.7bn | KRW 81.0bn | KRW 212.5bn | KRW 109.1bn | KRW 77.5bn | KRW |
| Total equity | KRW 566.0bn | KRW 622.4bn | KRW 815.7bn | KRW 894.0bn | KRW 1.0tn | KRW |
| Total liabilities | KRW 480.9bn | KRW 503.6bn | KRW 586.8bn | KRW 562.4bn | KRW 793.9bn | KRW |
| 부채비율(자체 계산: 부채총계 ÷ 자본총계 × 100, 자본 0 이하면 비움, 같은 해 같은 기준)· in house | 84.96 | 80.91 | 71.94 | 62.91 | 79.10 | % |
| Statement basis | Consolidated | Consolidated | Consolidated | Consolidated | Consolidated |
Show raw values
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | Unit |
|---|---|---|---|---|---|---|
| Revenue | 1,343,559,362,914 | 1,488,344,728,646 | 1,669,404,438,769 | 1,586,430,795,630 | 1,692,403,987,134 | KRW |
| Operating income | 94,758,694,014 | 109,906,061,531 | 246,599,279,042 | 99,461,546,115 | 80,567,677,778 | KRW |
| Net income | 42,720,380,723 | 80,953,361,433 | 212,521,171,442 | 109,072,842,041 | 77,508,541,109 | KRW |
| Total equity | 566,009,984,733 | 622,393,068,311 | 815,694,495,004 | 893,968,875,278 | 1,003,754,624,298 | KRW |
| Total liabilities | 480,890,428,784 | 503,593,995,766 | 586,793,266,763 | 562,386,857,139 | 793,942,540,356 | KRW |
| 부채비율(자체 계산: 부채총계 ÷ 자본총계 × 100, 자본 0 이하면 비움, 같은 해 같은 기준) | 84.96 | 80.91 | 71.94 | 62.91 | 79.10 | % |
Source: dart_fnltt · Computed in house · card as of 2026-10-13 · Filing date per year: not on the card (see the filing timeline below) · 'in house' marks items computed from the values above
② Profitability breakdown
Arithmetic on the fact table only · same year, same basis · '—' where a value is missing or the denominator is 0 or below · in each panel the bar height maps the span from the most negative to the largest positive value onto the panel height · no interpretation attached
Source: computed in house from the fact table · card as of 2026-10-13
③ My own calculation
A simple residual-income formula. You enter the assumptions; only the base equity is filled in from the filing. The result is computed from your assumptions and is not a figure this site publishes.
V = B₀ + (ROE − r) × B₀ ÷ (1 + r − ω)
Fill in all four boxes to compute. The site fills in nothing but the base equity.
Computed in this browser only; nothing you type is sent or stored.
- Base close 2026-10-13
- 65,900
- 80%
- 64,563.93 ~ 67,031.32
- 90%
- 64,142.59 ~ 67,702.33
- Ledger row
- f8cdff4b…
Source: fsc_stock_price · published 2026-10-14T11:05:08+09:00 · No direction implied
No day scored yet — no basis for a hit rate.
- 2026-10-08Filing title as filed최대주주등소유주식변동신고서 original ↗Source: dart_disclosure
- 2026-10-08Filing title as filed주식등의대량보유상황보고서(일반) original ↗Source: dart_disclosure
- 2026-10-08Filing title as filed임원ㆍ주요주주특정증권등소유상황보고서 original ↗Source: dart_disclosure
- 2026-10-08Filing title as filed임원ㆍ주요주주특정증권등소유상황보고서 original ↗Source: dart_disclosure
- 2026-10-08Filing title as filed주식등의대량보유상황보고서(일반) original ↗Source: dart_disclosure
- 2026-09-30Filing title as filed주식등의대량보유상황보고서(일반) original ↗Source: dart_disclosure
- 2026-08-31Filing title as filed주식등의대량보유상황보고서(일반) original ↗Source: dart_disclosure
- 2026-08-28Filing title as filed임원ㆍ주요주주특정증권등거래계획보고서 original ↗Source: dart_disclosure
- 2026-08-28Filing title as filed임원ㆍ주요주주특정증권등거래계획보고서 original ↗Source: dart_disclosure
- 2026-08-14Filing title as filed반기보고서 (2026.06) original ↗Source: dart_disclosure
- 2026-08-13Filing title as filed주식등의대량보유상황보고서(약식) original ↗Source: dart_disclosure
- 2026-07-31Filing title as filed영업(잠정)실적(공정공시) original ↗Source: dart_disclosure
- 2026-07-27Filing title as filed투자판단관련주요경영사항 (고혈압 치료제로 개발중인 CKD339의 식약처(MFDS) 제3상 임상시험 계획 승인) original ↗Source: dart_disclosure
- 2026-07-22Filing title as filed공정거래자율준수프로그램운영현황(안내공시) original ↗Source: dart_disclosure
- 2026-07-16Filing title as filed주식등의대량보유상황보고서(일반) original ↗Source: dart_disclosure
- 2026-07-01Filing title as filed주식등의대량보유상황보고서(약식) original ↗Source: dart_disclosure
- 2026-06-30Filing title as filed지속가능경영보고서등관련사항(자율공시) original ↗Source: dart_disclosure
- 2026-06-26Filing title as filed주식등의대량보유상황보고서(약식) original ↗Source: dart_disclosure
- 2026-06-24Filing title as filed주식등의대량보유상황보고서(일반) original ↗Source: dart_disclosure
- 2026-06-11Filing title as filed신규시설투자등 original ↗Source: dart_disclosure
| Layer | Badge | n | Note |
|---|---|---|---|
| range | unknown | 0 | 80%·90% 범위의 전향 적중 기록(목표일 개장 전 박제 → 종가 공표 뒤 채점) |
| fair_value | 제공 안 함 | 0 | 판별력 미확인 — 싣지 않음 |
| direction | 제공 안 함 | 0 | 판별력 미확인 — 싣지 않음 |
| trade_levels | 제공 안 함 | 0 | 판별력 미확인 — 싣지 않음 |
| Valuation estimate | not provided | — | Not published: no demonstrated discriminative power |
| Direction (up or down) | not provided | — | Not published: no demonstrated discriminative power |
| Trading levels | not provided | — | Not published: no demonstrated discriminative power |
Why this?
Checking…